| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 10/17/2001 | EP1146046A2 Pyropheophorbides and their use in photodynamic therapy |
| 10/17/2001 | EP1143991A2 Inhibitors of h+k+ -atpase |
| 10/17/2001 | EP0554434B1 Imaging of infections |
| 10/17/2001 | CN1073116C Metal-bonding cystein-free peptides, process for producing them and its pharmaceutical preparation |
| 10/16/2001 | CA2086244C Method of preparing a radioactive rhenium complex solution |
| 10/16/2001 | CA2044626C Type a platelet-derived growth factor receptor gene |
| 10/11/2001 | WO2001075110A2 Mucin-1 specific binding members and methods of use thereof |
| 10/11/2001 | WO2001074849A2 Binding peptides for carcinoembryonic antigen (cea) |
| 10/11/2001 | WO2001066139A8 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell |
| 10/11/2001 | WO2000076556A3 High dose radionuclide complexes for bone marrow suppression |
| 10/11/2001 | US20010029292 Sepsis |
| 10/11/2001 | US20010029020 In vitro determination of metastatic stomach, esophageal, and colorectal cancer from sampling cells outside of the colorectal track for gene transcript or protein |
| 10/11/2001 | US20010029019 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 10/11/2001 | CA2403998A1 Mucin-1 specific binding members and methods of use thereof |
| 10/11/2001 | CA2403242A1 Binding peptides for carcinoembryonic antigen (cea) |
| 10/10/2001 | EP1143253A1 Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
| 10/10/2001 | EP1140965A1 Protonated/acidified nucleic acids and methods of use |
| 10/10/2001 | EP1140873A1 Il-5 inhibiting 6-azauracil derivatives |
| 10/10/2001 | EP1140864A2 Vitronectin receptor antagonist pharmaceuticals |
| 10/10/2001 | EP1140290A2 Synergistic tumorcidal response induced by histamine |
| 10/10/2001 | EP1140212A2 The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning |
| 10/10/2001 | EP1140204A2 Vitronectin receptor antagonist pharmaceuticals |
| 10/10/2001 | EP1140167A1 Method for diagnosing, imaging, and treating tumors using restrictive receptor for interleukin 13 |
| 10/10/2001 | EP1140089A1 Liposomic niflumic acid - new transdermal anti-inflammatory medicine |
| 10/10/2001 | CN1072509C Re-188-rhenium sulfide suspension preparation, preparation method and its application |
| 10/09/2001 | US6299859 Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them |
| 10/09/2001 | US6299857 Cardiovascular and thrombus imaging agents, methods and kits |
| 10/09/2001 | US6299856 Introducing, at or near site of said malignancy, collagen covalently linked to a radioactive isotope or stable element subsequently activated to become radioactive isotope, in an effective amount to inhibit or reverse malignancy |
| 10/04/2001 | WO2001073133A1 Compositions and methods for identifying and targeting cancer cells |
| 10/04/2001 | WO2001073132A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 10/04/2001 | WO2001073131A1 High specificity marker detection |
| 10/04/2001 | WO2001072846A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 10/04/2001 | WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer |
| 10/04/2001 | WO2001072371A1 Radioactive implement and method of manufacture of same |
| 10/04/2001 | WO2001072342A1 Gastric emptying test-kit and method of testing gastric emptying of solid meal |
| 10/04/2001 | WO2001072203A2 Therapy of proliferative disorders by direct irradiation of cell nuclei with tritiated nuclear targeting agents |
| 10/04/2001 | WO2001032070A3 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 10/04/2001 | EP1138334A2 Pretargeting methods and compounds |
| 10/04/2001 | EP1137441A1 Ion exchange tumor targeting (iett) |
| 10/04/2001 | CA2404756A1 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 10/04/2001 | CA2404432A1 Compositions and methods for identifying and targeting cancer cells |
| 10/04/2001 | CA2404428A1 High specificity marker detection |
| 10/03/2001 | CN1315967A Bifunctional antibodies and their use in targeting anti-tumour agents |
| 10/03/2001 | CN1315208A 166 HO-DTPA, its preparing method and application as liquid radiation source |
| 10/03/2001 | CN1072020C One-step preparation for bicysteine ethylester medicine box of 99m TC-ECD brain perfusion imaging agent |
| 10/02/2001 | US6296846 Induced tolerance to xenografts |
| 10/02/2001 | US6296833 Administering compound that binds with specificity to a calcium-sensing receptor (car) and that is labeled with an agent that allows compound to be detected using in vivo imaging techniques; comparing; determining abnormal growth |
| 10/02/2001 | US6296831 Biodegradation; in cancer tumor therapy |
| 10/02/2001 | CA2116800C Agent for preventing adhesion of thallium 201 to container |
| 09/27/2001 | WO2001070807A2 G-protein associated molecules |
| 09/27/2001 | WO2001070755A1 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents |
| 09/27/2001 | WO2001070724A1 Radioisotope-labeled complexes of glucose derivatives and kits for the preparation thereof |
| 09/27/2001 | WO2001070699A1 Azure a analogues useful as probes in the diagnostic imaging for diseases due to accumulation of amyloid and compositions for diagnostic imaging containing the analogues |
| 09/27/2001 | WO2001070667A1 Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same |
| 09/27/2001 | WO2001070260A1 Cd18-binding antibodies inhibit stenosis-related disorders |
| 09/27/2001 | WO2001070095A2 Compositions and methods of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 09/27/2001 | US20010024639 Administering to a patient a contrast medium comprising a homogenous aqueous suspension of low density polymeric microsphere filled with a gas, scanning the patient using computed tomography imaging to obtain visible image of tissue |
| 09/27/2001 | US20010024636 Thermally reversible stimulus- sensitive gel or gelling copolymer radioisotope carrier that is a linear random copolymer of an (meth)acrylamide derivative and a hydrophil comonomer |
| 09/27/2001 | DE10012120A1 New ligand, comprising therapeutic or diagnostic agent bonded non-covalently with substance having high affinity to transport molecule |
| 09/27/2001 | CA2402747A1 G-protein associated molecules |
| 09/26/2001 | EP1135170A2 Radioconjugation of internalizing antibodies |
| 09/26/2001 | EP1135160A2 Boron neutron capture therapy using pre-targeting methods |
| 09/26/2001 | CN1314153A Mineral salt composition and its use |
| 09/26/2001 | CN1071580C 造影剂 Contrast agents |
| 09/25/2001 | US6294172 Monoclonal antibodies with specificity for membrane-associated antigens |
| 09/25/2001 | US6294151 Diagnosing the infection with urease-generating bacteria, particularly helicobacter pylori. |
| 09/20/2001 | WO2001068708A2 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | WO2001068679A2 Peptides targeting specifically tumor-derived endothelial cells |
| 09/20/2001 | WO2001068618A1 Bifunctional chelating agent |
| 09/20/2001 | WO2001068151A2 Functional radiographic imaging methods and agents |
| 09/20/2001 | WO2001068142A1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 09/20/2001 | DE10013286A1 New human humanized antibody that specifically binds to fibroblasts activating protein alpha, useful for treating cancer or tumor, and for imaging tumors associated with activated stromal fibroblasts, e.g. lung or breast cancer |
| 09/20/2001 | CA2402327A1 Peptides targeting specifically tumor-derived endothelial cells |
| 09/20/2001 | CA2401252A1 Human and humanized fap-alpha-specific antibodies |
| 09/19/2001 | EP1133494A1 8-azabicyclo 3.2.1]oct-2-ene and -octane derivatives |
| 09/19/2001 | EP0670736B1 Labelled interleukin-8 and medical uses thereof |
| 09/19/2001 | CN1313856A Thiazoline acid derivatives |
| 09/18/2001 | US6291639 Metal-binding cystein-free peptides for diagnostic and therapeutical purposes, methods for their production, and pharmaceuticals containing these compounds |
| 09/13/2001 | WO2001066156A2 Use of radiopharmaceuticals and intraoperative radiation probe |
| 09/13/2001 | WO2001066155A2 Actinium-225 complexes and conjugates for radioimmunotherapy |
| 09/13/2001 | WO2001066154A2 Radioactively labeled epothilone derivatives, method for the production thereof, and their biochemical and pharmaceutical use |
| 09/13/2001 | WO2001066152A1 Simultaneous multimodal measurement of physiological function |
| 09/13/2001 | WO2001066139A1 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell |
| 09/13/2001 | WO2001005805A3 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 09/13/2001 | US20010021533 Multi-partite ligands and methods of identifying and using same |
| 09/13/2001 | CA2402081A1 A compound that selectively binds to cd123 and use thereof to kill hematologic cancer progenitor cells |
| 09/12/2001 | EP1132394A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 09/12/2001 | EP1131343A1 Hydrophilic somatostatin analogs |
| 09/12/2001 | EP1131095A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 09/12/2001 | CN1312117A Pd-103 seed medicine and its prepn |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6287537 Radioimmunotherapy of lymphoma using anti-CD20 antibodies |
| 09/11/2001 | US6287536 Two-step pretargeting methods using improved bidtin-active agent conjugates |
| 09/11/2001 | US6287249 Thin film radiation source |
| 09/07/2001 | WO2001064743A1 GPib-LIPID BOND CONSTRUCT AND USE THEREOF |
| 09/05/2001 | EP1128872A1 Radioactive brachytherapy source and material and manufacturing method therefore |
| 09/05/2001 | EP1128848A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers |
| 09/04/2001 | US6284491 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 09/04/2001 | US6284219 In vivo determination of metabolic function for use in therapy management |
| 09/04/2001 | CA2167281C Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |